GR3004966T3 - - Google Patents

Info

Publication number
GR3004966T3
GR3004966T3 GR920401300T GR920401300T GR3004966T3 GR 3004966 T3 GR3004966 T3 GR 3004966T3 GR 920401300 T GR920401300 T GR 920401300T GR 920401300 T GR920401300 T GR 920401300T GR 3004966 T3 GR3004966 T3 GR 3004966T3
Authority
GR
Greece
Prior art keywords
agent
colestyramin
endowed
pharmaceutical composition
active principle
Prior art date
Application number
GR920401300T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004966T3 publication Critical patent/GR3004966T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
GR920401300T 1986-06-16 1992-06-18 GR3004966T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20799/86A IT1190349B (it) 1986-06-16 1986-06-16 Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle

Publications (1)

Publication Number Publication Date
GR3004966T3 true GR3004966T3 (el) 1993-04-28

Family

ID=11172237

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401300T GR3004966T3 (el) 1986-06-16 1992-06-18

Country Status (8)

Country Link
US (1) US4902501A (el)
EP (1) EP0251369B1 (el)
JP (1) JPS62298533A (el)
AT (1) ATE76297T1 (el)
DE (1) DE3779189D1 (el)
ES (1) ES2044912T3 (el)
GR (1) GR3004966T3 (el)
IT (1) IT1190349B (el)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3808191C2 (de) * 1988-03-11 1998-08-06 Astra Chem Gmbh Colestyramin enthaltende pharmazeutische Zusammensetzung
EP0420875B1 (en) * 1988-06-24 1993-07-21 The Upjohn Company Fine-milled colestipol hydrochloride
EP0447362A1 (en) * 1990-03-13 1991-09-18 Warner-Lambert Company Improved ingestible anion exchange resin delivery system compositions containing adipic acid
US5091175A (en) * 1990-05-14 1992-02-25 Erbamont Inc. Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
US5137716A (en) * 1990-11-15 1992-08-11 Weisenfeld Michael S Method of reducing weight in mammals
US5830452A (en) * 1990-11-20 1998-11-03 Chiron Corporation Method for enhancing the anti-tumor therapeutic index of interleukin-2
CA2042870C (en) * 1991-05-17 1996-11-26 Leon Edward St. Pierre Metal ion coordinated polyamine resins for the lowering of blood cholesterol
IT1306171B1 (it) * 1999-07-21 2001-05-30 Wiktor Djaczenko Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2-
US7527807B2 (en) * 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
WO2002009814A2 (en) * 2000-07-28 2002-02-07 F. Hoffmann-La Roche Ag New use of lipase inhibitors
CZ302087B6 (cs) * 2000-07-28 2010-10-06 F. Hoffmann-La Roche Ag Farmaceutický prípravek obsahující orlistat spolu se sekvestrantem žlucových kyselin pro použití pro lécení a prevenci obezity
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
GB2430367B (en) 2004-03-30 2009-08-05 Ilypsa Inc Ion binding polymers and uses thereof
US7556799B2 (en) 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US7854924B2 (en) * 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US8192758B2 (en) * 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
US7429394B2 (en) * 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
AU2006242535B2 (en) * 2005-04-29 2012-08-09 Merck Sharp & Dohme Corp. Therapeutic compositions
JP5595660B2 (ja) 2005-09-15 2014-09-24 ジェンザイム コーポレーション アミンポリマー用サシェ製剤
AU2006294455B2 (en) * 2005-09-30 2013-06-20 Relypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
CN101316601A (zh) 2005-09-30 2008-12-03 伊立普萨公司 从哺乳动物的胃肠道选择性除去钾离子的方法和组合物
US20100104527A1 (en) * 2008-08-22 2010-04-29 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
EP2365988B2 (en) * 2008-08-22 2019-07-03 Vifor (International) Ltd. Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia
US8337824B2 (en) 2008-08-22 2012-12-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
AU2013329451B2 (en) 2012-10-08 2018-08-09 Vifor (International) Ltd. Potassium-binding agents for treating hypertension and hyperkalemia
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2838440A (en) * 1953-10-29 1958-06-10 Rohm & Haas Dusting powder of carboxylic cationexchange resin and powder base
NL7017227A (el) * 1969-12-27 1971-06-29
NL7311319A (el) * 1972-09-01 1974-03-05
GB1566609A (en) * 1977-03-10 1980-05-08 Reckitt & Colmann Prod Ltd Pharmaceutical compositions containing cholestyramine and alginic acid
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
BE896241A (fr) * 1983-03-22 1983-07-18 Prosan Internat Composition antidiarrheique a usage veterinaire et methode d'utilisation de cette composition

Also Published As

Publication number Publication date
ES2044912T3 (es) 1994-01-16
EP0251369A3 (en) 1988-05-11
DE3779189D1 (de) 1992-06-25
ATE76297T1 (de) 1992-06-15
IT8620799A0 (it) 1986-06-16
JPS62298533A (ja) 1987-12-25
IT8620799A1 (it) 1987-12-16
EP0251369A2 (en) 1988-01-07
IT1190349B (it) 1988-02-16
US4902501A (en) 1990-02-20
EP0251369B1 (en) 1992-05-20

Similar Documents

Publication Publication Date Title
GR3004966T3 (el)
IL96400A0 (en) Herbicidal compositions containing an imizapyr analog together with another active agent
CZ8193A3 (en) Pharmaceutical dosing form with prolonged release of active compound
HUT41418A (en) Process for producing pharmaceutical compositions containing anticoagulator polipeptides and process for producing the active agents
GR3006177T3 (el)
NZ216632A (en) Multi-component, aqueous polymer compositions containing c 16 + aliphatic surface active compound as evaporation retarding agent
PH30439A (en) 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same
IT8919413A0 (it) Composizione avente attivita' battericida oppure batteriostatica.
ZA90946B (en) Medicament containing dihydrolipoic acid as active substance
IL106562A0 (en) Pharmaceutical and/or cosmetic compositions and the use thereof
HUT41765A (en) Herbicide composition containing 5-amino-1-pyridyl-pyrazole derivatives and process for producing the active agents
HUT41957A (en) Insecticide compositions containing aryl-pyridon derivatives as active agents and process for producing the active agents
IL91047A0 (en) Pharmaceutical compositions containing a zinc complex
IL90551A (en) Stable, injectable, aqueous pharmaceutical compositions for the treatment of cardiac conditions
ZA906383B (en) Long active injectable formulations containing triacetin
ZA9110018B (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity.
IL80900A0 (en) Pharmaceutical composition for treatment of thrombosis containing fibrinolytic compounds and prostacyclin derivatives
NZ223200A (en) Anthelmintic compositions containing 2',5-dicloro-4'-nitrosalicylanilide and non aqueous carrier
HUT41206A (en) Fungicide compositions containing alpha-oximino-alpha-carbamoyl-acetonitril derivatives as active agents and process for producing the active agents
ZA881373B (en) Dispenser for the application of active components
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
HUT41764A (en) Herbicide compositions containing 5-amino-4-cyano-1-pyridyl-pyrazole derivatives as active agents and process for producing the active agents
EP0495106A4 (en) Osteogenesis promoter
HUT41757A (en) Process for producing pharmaceutical compositions containing e-desmethyl-mevalonic acid derivatives and process for producing the active agents
HUT41965A (en) Insecticide compositions containing s,s-di/terc-alkyl/-thiophosphonate derivatives as active agents and process for producing the active agents